Immunohematology Market Size, by Technology, Growth, Application & Geography – Analysis & Forecast to 2024
U.S. immunohematology market held the largest revenue share of USD 616.5 million in 2017 and will show similar trend during the forecast timeframe. Increasing prevalence of hematological disorders such as sickle cell anemia, leukemia and thalassemia will serve to be a major impact rendering factor in the market growth. Furthermore, strong foothold of well-established industry players in the country will further accelerate the U.S. immunohematology business growth.
View full press release